IMVT TED
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Don O. Kikkawa, MD, FACS is the recipient of the 2022 UW-Madison Ophthalmology Alumni Association’s Distinguished Alumni Award. Kikkawa, who completed his fellowship in oculoplastics at UW-Madison in 1992, said he was drawn to the Department of Ophthalmology and Visual Science fellowship program for its stature as the top program of its kind. He feels …
A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)